Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Temozolomide IP 100 mg Capsule
Therapeutic Category
Oncology
Dosage Form
Capsule
Packaging Type
in a Bottle
Packaging
5 Capsule
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Temofan 100 Capsule (Temozolomide IP 100 mg) is a highly specialized, oral cytotoxic chemotherapy drug classified as an Alkylating Agent. It is the standard treatment backbone for patients diagnosed with the aggressive primary brain tumor, Glioblastoma Multiforme (GBM).
Mechanism and Impact:Temozolomide rapidly converts to its active metabolite, MTIC, which is crucial because it can effectively cross the Blood-Brain Barrier (BBB) to target tumor cells in the central nervous system. MTIC causes DNA damage that triggers cell death. The Capsule form is the standard and preferred way to deliver this life-saving drug to patients at home during the long-term adjuvant phase.
Key Therapeutic Uses:
GBM: Used concurrently with radiation therapy and subsequently as adjuvant monotherapy.
Anaplastic Astrocytoma: Used for patients who have relapsed or progressed.
Due to its high specialization and critical role in treating brain cancer, Temozolomide 100 mg commands a premium market segment. We offer an exclusive PCD Pharma Franchise opportunity for Temofan 100 Capsule, ensuring partners access a high-value, niche neuro-oncology market with a trusted dosage form.
Possible side effects include stomach upset, nausea, dizziness, or diarrhea. Rarely, allergic reactions or gastrointestinal bleeding may occur.
Mefasil Suspension is indicated for the relief of mild to moderate pain and inflammation, including headaches, menstrual pain, and musculoskeletal pain.
Use this medication as prescribed by your doctor. Avoid exceeding the recommended dosage. Inform your doctor of any existing medical conditions or ongoing medications.
Store the suspension in a cool, dry place, away from direct sunlight. Shake well before use. Keep out of reach of children.
Composition : Paracetamol (250mg/5ml)
Composition : Ibuprofen (100mg) + Paracetamol (125mg)
Composition : Paracetamol (1000mg) Infusion
Composition : Ketorolac (30mg) Injection
Composition : Mefenamic Acid (100mg) + Paracetamol (250mg)
Composition : Mefenamic Acid (50mg) + Paracetamol (125mg)
Composition : Diclofenac diethylamine (1.16% w/v) + Linseed Oil (3% w/v) + Methyl Salicylate (10% w/v) + Menthol (5% w/v)
Composition : Diclofenac diethylamine (1.16% w/w) + Thiocolchicoside (0.125% w/w) + Linseed Oil (3.0% w/w) + Methyl Salicylate (10.0% w/w) + Menthol (5.0% w/w)
Composition : Choline Salicylate (8.7% w/w) + Lidocaine (2.0% w/w) + Benzalkonium Chloride (0.01% w/w) Gel
Composition : Flupirtine (100mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Temozolomide IP 100mg Capsule has strong demand in the oncology, neuro-oncology, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on oncology and high-value specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from consistent demand for oncology treatments under specialist medical supervision. Temozolomide IP 100mg is an oral alkylating antineoplastic (chemotherapy) agent used in the treatment of certain brain tumors Commonly prescribed for the management of newly diagnosed glioblastoma multiforme (GBM) in combination with radiotherapy, and for recurrent or refractory anaplastic astrocytoma and other selected brain tumors, as advised by oncologists Helps inhibit the growth and multiplication of cancer cells by damaging their DNA, thereby slowing disease progression The 100mg capsule strength provides dosing flexibility and is commonly used in combination with other capsule strengths to achieve individualized doses based on the patient's body surface area and treatment protocol Requires strict medical supervision with regular monitoring of blood counts, liver function, and overall treatment response due to the risk of bone marrow suppression and other adverse effects Frequently utilized in oncology centers, neuro-oncology clinics, tertiary care hospitals, and cancer specialty hospitals Widely prescribed by medical oncologists, neuro-oncologists, and radiation oncologists This strengthens a comprehensive oncology and specialty healthcare portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Temozolomide IP 100mg Capsule with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent specialty prescription demand, high-value oncology market opportunities, institutional procurement, reliable supply chain support, and attractive margins in the oncology segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality oncology products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.